$MRK Recent News Merck, McDonald's are top decliners in

New Post Public Reply Private Reply Replies (0) Message Board

Dec 4, 2013 at 4:23 PM

$MRK Recent News

Merck, McDonald's are top decliners in Dow index 18 min ago - Polya Lesova
Cuts, stock buyback, acquisition combine to boost Forest shares 11:09 a.m. Dec. 2, 2013 - blogs.marketwatch.com
Merck, J.P. Morgan lead Dow decliners 9:35 a.m. Nov. 13, 2013 - Laura Mandaro
Merck, Cisco lead gainers in Dow industrials 4:03 p.m. Nov. 12, 2013 - Polya Lesova
Bitcoin buying for dummies 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Planned layoffs up 13.5% in October: Challenger 7:30 a.m. Nov. 6, 2013 - Steve Goldstein
Newscast: S&P 500 notches year's 32nd record high 8:08 p.m. Oct. 28, 2013 - MarketWatch
J.C. Penney, Bristol-Myers top S&P 500 7:08 p.m. Oct. 28, 2013 - Saumya Vaishampayan
S&P up for 8th day in 9; Dow, Nasdaq flat 4:57 p.m. Oct. 28, 2013 - Victor Reklaitis
Newscast: Stocks mixed after lackluster day 4:26 p.m. Oct. 28, 2013 - MarketWatch
Newscast: Car reliability ranks get new members 2:28 p.m. Oct. 28, 2013 - MarketWatch
Merck shares stumble on earnings weakness, talk of divesting assets 10:58 a.m. Oct. 28, 2013 - blogs.marketwatch.com
Merck, down 2.2%, leads Dow average lower 9:34 a.m. Oct. 28, 2013 - Laura Mandaro
Stock futures continue to waver after data 9:30 a.m. Oct. 28, 2013 - Sara Sjolin
Apple is Monday’s stock to watch as results loom 8:21 a.m. Oct. 28, 2013 - Sue Chang
Merck profit down 35% as Singulair sales fall 7:25 a.m. Oct. 28, 2013 - MarketWatch.com
Merck third-quarter profit, revenue fall 7:17 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck narrows 2013 EPS guidance; holds sales view 7:10 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 adj. EPS edges down to $0.92 vs. $0.95 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan
Merck Q3 sales down to $11.03 bln vs. $11.49 bln 7:03 a.m. Oct. 28, 2013 - Saumya Vaishampayan

Merck, Procter & Gamble Fall as Market Shrugs Off Taper Fears 6 min ago - TheStreet.com
Biotech Stock Predictions 2014: Vertex is Bought, Alexion Sinks, BlueBird Flies And More 11:35 a.m. Today - TheStreet.com
Meet the Preliminary 2014 Dogs of the Dow: Dividends Galore 11:09 a.m. Today - 247WallSt.com
Health Care Heartiest, Gold Funds All Red In November 5:41 p.m. Dec. 3, 2013 - Investors Business Daily
Forest Labs Up on Strategic Initiatives - Analyst Blog 1:25 p.m. Dec. 3, 2013 - Zacks.com
4 Reasons Tonix Could Be A Multi-Bagger 10:30 a.m. Dec. 3, 2013 - Seeking Alpha
Will GlaxoSmithKline Head Higher After Recent Headlines? 8:53 a.m. Dec. 3, 2013 - Wall St. Cheat Sheet
Pharma & Biotech Stock Outlook - Dec 2013 - Zacks Analyst Interviews 4:28 a.m. Dec. 3, 2013 - Zacks.com
Pharma & Biotech Stock Outlook - Dec 2013 - Industry Outlook 4:28 a.m. Dec. 3, 2013 - Zacks.com
Forest Labs to Cut 500 Jobs in Restructuring 7:31 p.m. Dec. 2, 2013 - WSJ.com
Merck and Seadrill Top GuruFocus Dividend Growers of the Week 4:56 p.m. Dec. 2, 2013 - GuruFocus.com
Merck: The Good, The Bad And The Ugly 2:46 p.m. Dec. 2, 2013 - Seeking Alpha
Today's Momo Momentum Stock To Watch: Merck (MRK) 1:59 p.m. Dec. 2, 2013 - TheStreet.com
Forest Labs acquires rights to schizophrenia treatment from Merck 10:11 a.m. Dec. 2, 2013 - Seeking Alpha
Losing Some Sparkle to Buybacks 3:10 a.m. Nov. 30, 2013 - Barrons.com
Merck's Noxafil Tablets Approved by the FDA - Analyst Blog 11:30 a.m. Nov. 29, 2013 - Zacks.com
Buy Today: Merck & Co Inc's Buy Recommendation Reiterated 9:00 a.m. Nov. 29, 2013 - TheStreet.com
Drug Stocks: Winners, Losers, in Statin Shift 10:41 p.m. Nov. 27, 2013 - Barrons.com
Updated statin guidelines give AstraZeneca the upper hand: Barron's 10:54 a.m. Nov. 27, 2013 - Seeking Alpha
GlaxoSmithKline: What's The Next Growth Driver? 2:38 p.m. Nov. 26, 2013 - Seeking Alpha

Increased Quarterly Dividends, HIV Elimination Efforts, Advanced Treatment Options, and Conference Participations - Research Report on Merck, Varian, Mylan, Achillion, and Abiomed 8:00 a.m. Today - PR Newswire
Intarcia Therapeutics Appoints Nancy Thornberry to Board of Directors 2:37 p.m. Dec. 2, 2013 - PR Newswire
Forest to Acquire U.S. Marketing Rights to Saphris(R) (asenapine) from Merck 9:00 a.m. Dec. 2, 2013 - BusinessWire
EMD Serono's New Spin-off TocopheRx to Focus on Infertility Treatment 8:30 a.m. Dec. 2, 2013 - BusinessWire
FDA Approvals, Stock Price Updates, New Study Results, Conference Schedules and Partnerships - Research Report on Merck, Pharmacyclics, UnitedHealth Group, Medtronic, and AstraZeneca 8:00 a.m. Nov. 29, 2013 - PR Newswire
Merck Announces Increased Quarterly Dividend 2:18 p.m. Nov. 26, 2013 - BusinessWire
FDA Approves Merck's NOXAFIL(R) (posaconazole) Delayed-Release Tablets 9:00 a.m. Nov. 26, 2013 - BusinessWire
Stock Price Movements and Program Launches Reported by Healthcare Companies - Research Report on Merck, Abiomed, Alere, Raptor Pharmaceuticals and West Pharmaceutical Services 8:00 a.m. Nov. 26, 2013 - PR Newswire
SiSense Wins Quarter Million Dollar Prize, Takes Top Honor in "Take the H.E.L.M." Competition 11:30 a.m. Nov. 25, 2013 - PR Newswire
Mondo Guerra and the Merck HIV Educational Campaign I Design Invite the Community to Pledge Action in Honor of World AIDS Day 8:01 a.m. Nov. 25, 2013 - PR Newswire
ARMO BioSciences Initiates Phase 1 Clinical Trial of First-In-Class Cancer Immunotherapy 8:00 a.m. Nov. 25, 2013 - PR Newswire
European Patent Office Issues Decision Regarding Universal Display's Organometallic Iridium Patent 9:01 a.m. Nov. 22, 2013 - BusinessWire
Sixth Annual Biotech Showcase(TM) Returns to San Francisco January 13-15 6:51 p.m. Nov. 21, 2013 - BusinessWire
FDA Approvals, Stock Price Movements, and Study Results - Research Report on Pfizer, Celgene, Merck, Quest Diagnostics, and Pharmacyclics 8:00 a.m. Nov. 21, 2013 - PR Newswire
Merck Consumer Health Turnaround on Track 4:00 a.m. Nov. 21, 2013 - BusinessWire
Critical Alerts For Netflix, Salesforce.com, Goldman Sachs, Merck, and Valero Energy Released By InvestorsObserver 9:31 a.m. Nov. 19, 2013 - PR Newswire
Merck for Mothers Working to End the Tragedy of Women in America Dying in Childbirth and Pregnancy 8:30 a.m. Nov. 19, 2013 - PR Newswire
Additional Interim Data for Merck's Investigational Anti-PD-1 Immunotherapy, MK-3475, Shows Estimated Overall Survival Rate of 81 Percent at One Year in Patients with Advanced Melanoma 12:00 p.m. Nov. 18, 2013 - BusinessWire
Merck Partners With TRUSTe to Become Certified Under APEC Cross Border Privacy Rules 9:00 a.m. Nov. 18, 2013 - Marketwire
Merck's New Drug Application for an Investigational Intravenous (IV) Formulation of NOXAFIL(R) (posaconazole) Receives FDA Priority Review 8:30 a.m. Nov. 18, 2013 - BusinessWire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MongoDB Faces Continued Legal Scrutiny Amid Growth Issues

MongoDB's Legal Marmite: Sticky and Spreading Well, here we are, rolling up our sleeves with MongoDB, Inc. (NasdaqGM: MDB) in the spotlight again, not for some glorious tech breakthrough but a legal brouhaha. The whip of the market is as familiar as an old leather boot to traders like us. This time, we've got Kahn Swick & Foti, LLC (KSF), spearheaded by former Attorney...

ModelBest & OpenBMB Unveil Open-Source OCR Models

A New Frontier in Document Parsing Just when you thought document parsing couldn't get any more advanced, ModelBest and OpenBMB come along with a game-changing release: the MiniCPM-OCR series. This duo of dynamite models, MiniCPM-OCR 1.0 and Jev, is all about taking the efficiency and performance expectations for open-source OCR models up a couple of notches. If you're an...

UBCF Strikes Big in Times Square with New Billboards

From the Shadows to the Spotlight Ever seen someone step up to the plate and knock it out of the park? That's what the United Breast Cancer Foundation (UBCF) is doing by plastering their mission right across Times Square. Talk about grabbing the bull by the horns, eh? With not one, but two billboards now gracing one of the globe's most iconic public spaces, they've...

Fashion and Philanthropy Unite at UBCF Kick-off Party

Exclusivity and Dedication Mix at UBCF Event When fashion and philanthropy get together, you better believe it's more than just a pleasant evening. The Frederick Anderson Collection is hosting a swanky cocktail reception, kicking off the United Breast Cancer Foundation's (UBCF) highly-anticipated Think Pink Gala, and it's shaping up to be a unique affair wrapped in...

Rural AI Skills Gap Uncovered: Challenges and Solutions

Rural Workers Face Distinct AI Challenges Ah, life in the countryside might sound serene, but when it comes to keeping up with AI, rural folks aren't sipping lemonade and waiting on a windfall. The newly unveiled paper from the University of Phoenix College of Doctoral Studies shines a floodlight on some hefty challenges facing rural communities—particularly around...

CMRE Facing Legal Heat Over Wage Allegations

Another Day, Another Lawsuit Ah, work. It’s what gets us up in the morning, whether we like it or not. Yet, for many, it can feel more like a dubious hustle when the rewards don't match the effort. Now, CMRE Financial Services, Inc. finds itself under the legal microscope, thanks to a fresh class-action lawsuit filed by the legal eagles at Blumenthal Nordrehaug Bhowmik...

SAMILBIO Gambles on 'Chaeyun' Launch With November Events

Can SAMILBIO's New Products Make a Splash? In a world where skincare is more competitive than a hot dog stand outside a vegan festival, here comes SAMILBIO with their latest offerings. Launching a whitening cream and an acne-fighting gel under the 'Chaeyun' brand, this company isn't just sticking to digital—it's diving into face-to-face consumer interaction. I mean,...

iTLC Traffic Systems Expand Global Reach at APTA 2026

APTA 2026: The Launchpad for Intelligent Traffic Control Forget the days of manual traffic chaos—by the sounds of it, smart intersections are ready to rule the roads. Today's chatter at APTA 2026 in Chicago was a whirlwind of ideas, all centered around how ICP DAS and Towards Buddha Co., Ltd. plan to shake up traffic management globally with their iTLC Intelligent...

Duolingo Investors Must Weigh Legal Options Now

Pressure Mounts on Duolingo Amid Legal Turmoil Well, here's a riddle solved with a lawsuit: when an app's growth hits the brakes, the lawyers seem to get moving fast. It seems like Duolingo, Inc. (NasdaqGS: DUOL) is learning a harsh lesson—not exactly in Spanish or French, but in the courtroom. They've been slapped with a securities class action, and it ain't looking...

Everest Group Faces Class Action: Key Deadlines Looming

Everest Group's Legal Quagmire: A Rocky Road Ahead Riding high has its pitfalls. I mean just take a gander at Everest Group, Ltd. (NYSE: EG). The suits and stocks got their knickers in a twist when the company's missteps saw them landing smack dab in the middle of a shareholder class-action lawsuit. It's gloomy days, my friend, especially if you're carrying a portfolio...